Tenderwize
Back to tender search

Open House Originale Rabattverträge 2025-16 - Empagliflozin

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 315 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-16 - Empagliflozin

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated contract value is disclosed, making it impossible to assess potential revenue.

Contract ends automatically upon patent expiry or loss of market exclusivity, which could shorten the contract term.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Conclusion of rebate contracts for Empagliflozin as per § 130c SGB V.
  • Standardized contract terms; no individual negotiations.
Show full summary

Open House procedure for concluding rebate contracts (Rabattverträge) according to § 130c SGB V for the active ingredient Empagliflozin. The procedure is open to all eligible pharmaceutical entrepreneurs, with standardized contract terms and no exclusivity. The contract runs from July 1, 2025, to June 30, 2027. Participation is possible at any time during this period. No estimated contract value is provided.

Risks

No estimated contract value is disclosed, making it impossible to assess potential revenue.

Contract ends automatically upon patent expiry or loss of market exclusivity, which could shorten the contract term.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4(18) AMG.
  • Valid marketing authorization for the offered medicinal product.

Eligibility

  • Self-declaration of eligibility and reliability required.

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-16 - Empagliflozin

Rebate contracts for the active ingredient Empagliflozin. The contract is open to all pharmaceutical entrepreneurs who meet the eligibility criteria. No individual negotiations; standardized conditions apply.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Deadline

Deadline Jun 29, 2027

Procurement Details

Publication date
22 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
334433-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24